In malignant gliomas, GLS2 is commonly downregulated (as we observed in Figure 1E) [32], but GLS1 is the predominant enzyme in the brain, since it is expressed at higher levels than GLS2 [33], allowing for the hydrolysis of glutamine. The gene discussed is GLS; the disease is malignant glioma.